Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., . . . Zannad, F. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. The New England journal of medicine, 383, . https://doi.org/10.1056/NEJMoa2022190
Chicago Style (17th ed.) CitationPacker, Milton, et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." The New England Journal of Medicine 383 (2020). https://doi.org/10.1056/NEJMoa2022190.
MLA (9th ed.) CitationPacker, Milton, et al. "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure." The New England Journal of Medicine, vol. 383, 2020, https://doi.org/10.1056/NEJMoa2022190.
Warning: These citations may not always be 100% accurate.